HIV/AIDS Associated Lymphoma: Review
Blood and Lymphatic Cancer: Targets and Therapy · 2022-04 · Volume 12 · 31-45
DOI: 10.2147/blctt.s361320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2022-04. Verfasst von Ayenew Berhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
- Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
ORCID-Profile: Ayenew Berhan, Biruk Bayleyegn, Zegeye Getaneh
Zitieren
APA
Berhan, A., Bayleyegn, B., & Getaneh, Z. (2022). HIV/AIDS Associated Lymphoma: Review. Blood and Lymphatic Cancer: Targets and Therapy, Volume 12, 31-45. https://doi.org/10.2147/blctt.s361320
Vancouver
Berhan A, Bayleyegn B, Getaneh Z. HIV/AIDS Associated Lymphoma: Review. Blood and Lymphatic Cancer: Targets and Therapy. 2022;Volume 12:31-45. doi:10.2147/blctt.s361320
BibTeX
@article{Berhan2022,
author = {Berhan, Ayenew and Bayleyegn, Biruk and Getaneh, Zegeye},
title = {HIV/AIDS Associated Lymphoma: Review},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2022},
volume = {Volume 12},
pages = {31--45},
doi = {10.2147/blctt.s361320}
}
EUVIMED